Navigation Links
Dr. Lark Creates Nutritional Supplement to Restore Thick Hair and Strong Nails
Date:10/16/2008

in their scalp and hair health. That's the exact amount you'll find in Hair & Nails Revitalizer.
  • Salvia Seed Oil -- Essential fatty acids (EFAs) are critical to bring luster back to dull and brittle hair and nails. Plus, they're necessary for hydration. Salvia seed oil is a potent source of alpha linolenic acid, which is rich in omega-3 EFAs, and also contains omega-6 and omega-9 EFAs. These moisturizing oils are the key to promoting healthy hair and nails.
  • Keratin Cynatine FLX™ -- Hair and nails are made of a hard protein called keratin. Dr. Lark has found a powerful form of soluble keratin from New Zealand, Keratin Cynatine FLX, that's been shown to promote the structural integrity of collagen, which helps strengthen hair and nails.
  • Biotin--One of the B-complex vitamins, biotin is known to strengthen brittle fingernails in humans. It also has antioxidant effects that help maintain healthy hair, skin, and nails. In fact, studies suggest that biotin supplementation increases nail plate thickness in people with brittle nails.
  • Silica--This critical nutrient makes hair strong and shiny and nails long and hard. But as we get older, our silica levels may drop. Dr. Lark has found that the best way to get silica is through a unique plant called horsetail. It's naturally rich in nutrients like silica and has been traditionally used for decades to support the strength of nails.
  • "Hair and nail changes are very common issues for women as they get older and reach menopause. The good news is that you can regain your appearance and restore your hair and nails," says Linda Werner, Vice President and General Manager, Women's Health at Healthy Directions, LLC. "I believe Dr. Lark's Hair & Nails Revitalizer delivers the best nutrients to hydrate, protect and strengthen your hair and nails."

    Dr. Lark has devoted her career to raising awareness of women's health issues, such as PMS, obesity, h
    '/>"/>

    Source: PRWeb
    Copyright©2008 Vocus, Inc.
    All rights reserved

    Page: 1 2 3

    Related medicine news :

    1. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
    2. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
    3. Exceptional Childrens Foundation Merger with Kayne Eras Center Creates One of States Most Comprehensive Nonprofits Serving the Disabled
    4. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
    5. L.A. Playwright Creates an Enormous Wave with His New Book, Touch the Ocean
    6. Alter+Care Creates the Advisory Board
    7. Hollings Cancer Center Creates $1 Million Endowed Chair for Breast Cancer Research and Treatment with Gift from the Spaulding-Paolozzi Foundation
    8. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
    9. Creative Technology Services Creates a New Operating Company Focused on Mobility
    10. inVentiv Health Creates Client Development and Integration Team
    11. National Heart Lung and Blood Institute creates national network to study cardiovascular disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/5/2015)... AxoGen, Inc. (NASDAQ: AXGN) , ... nerve repair market, reported record revenue of $4.79 million ... to $2.98 million in the year-ago fourth quarter demonstrating ... , “Our strong fourth quarter revenue growth reflects the ... which is driving increased surgeon adoption of our unique ...
    (Date:3/5/2015)... NY (PRWEB) March 05, 2015 ... forward in a Pennsylvania mass tort litigation currently ... where a jury has begun hearing testimony in ... the atypical antipsychotic medication can cause gynecomastia, or ... case in question was filed on behalf of ...
    (Date:3/5/2015)... 05, 2015 Testosterone lawsuits ( http://www.testosteronelawsuithub.com/ ... heart attacks, strokes and other serious cardiovascular events due ... to move forward in the federal multidistrict litigation now ... According to a Case Management Order issued on March ... use of master pleadings in the proceeding. Among other ...
    (Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased to ... new logo and optimized website. , CNI’s ... to expert diagnostic imaging, centered on patient care. The ... be a resource for Nebraska patients and a tool ... and referral functionality, video content and resources to understand ...
    (Date:3/5/2015)... RI (PRWEB) March 05, 2015 Rhode Island ... third year in a row to support the Providence College ... The donation covered the purchase of the ‘Think Pink’ uniforms, ... against Big East Conference opponent DePaul University at Alumni Hall/Mullaney ... to continue our support of the PC women’s basketball’s ‘Pink ...
    Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2
    ... Drug Information Association (DIA), in collaboration with FDA, the Medical ... Radiopharmaceuticals (CORAR), PhRMA, and the American Medical Informatics Association (AMIA), ... Uses of Medical Imaging in the Development of New Biopharmaceutical ... ...
    ... is a break-through Nitinol wire product which features an exclusive ... acid solutions which cause embrittlement. The resulting NitiBrite™ ... other known methods. , ... West ...
    ... Komen for the Cure(R), the,leader of the global ... G. Komen for the Cure Advocacy Alliance, have ... self awareness and the need for,increased access to ... (Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO ), Komen for the ...
    ... Companies Will Discuss Recent FDA Advisory Regarding Byetta, ... LLY ) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... 2008 at 5:00 p.m. EDT to discuss the,recent FDA ... Lilly will be Donald Therasse, M.D., vice president of ...
    ... fail to alert docs to effectiveness of alternative therapies ... slowed the use of antipsychotic drugs in seniors with ... the elderly increased, a finding which suggests that warnings ... say. , Between late 2002 and June 2005, ...
    ... HCA marked its 40th,anniversary during a special program for ... featured HCA Co-Founder and Chairman Emeritus, Dr. Thomas,Frist, Jr. ... who spoke about,HCA,s founding, mission and tradition of caring ... of Caring" program was a,prelude to HCA,s annual Caring ...
    Cached Medicine News:Health News:Shaping Best Practices For Standardized Medical Imaging In Clinical Trials 2Health News:Shaping Best Practices For Standardized Medical Imaging In Clinical Trials 3Health News:NitiBrite™ - Break-through in Nitinol Wire Product for Medical Devices 2Health News:Komen Travels to Democratic Convention in Denver to Raise Awareness of Breast Cancer Issues 2Health News:Lilly and Amylin Set Date and Time for Conference Call 2Health News:Antipsychotic Drug Use Up in Elderly Despite Warnings 2Health News:HCA Celebrates 40th Anniversary 2
    (Date:3/5/2015)... Corporation (Nasdaq: IRIX ) today reported financial results ... , Revenues were $11.8 million in the fourth ... 11% from $10.6 million in the 2013 fourth quarter. Revenues ... from $38.3 million in 2013. , Gross margin for ... the fourth quarter of the prior year. , Operating ...
    (Date:3/5/2015)... SEATTLE und TÜBINGEN, Deutschland, 5. ... Melinda Gates Stiftung und das deutsche biopharmazeutische ... Stiftung 46 Millionen Euro (52 Millionen US-Dollar) ... im Bereich der medizinisch angewandten Messenger-RNA (mRNA). ... neue Ansätze zur Behandlung von Krankheiten und ...
    (Date:3/5/2015)... TÜBINGEN, Germany , March 5, ... Foundation and CureVac today announced that the foundation ... (€46 million) in CureVac, a leading clinical-stage biopharmaceutical ... of the agreement, the foundation will also provide ... vaccines based on CureVac,s proprietary messenger RNA (mRNA) ...
    Breaking Medicine Technology:IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 2The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 3The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 4
    ... 16 According to the Centers for Disease Control and ... influenza activity - and nearly all influenza cases reported to ... flu. However, with the release of a 2009 H1N1 ... help keep their families safe from illness. , Like seasonal ...
    ... Oct. 15 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ... M. Culley, will present at the BIOCOM Investor Conference on ... the Hyatt Regency in La Jolla, California. , Interested parties ... the ADVENTRX Pharmaceuticals Web site at www.adventrx.com ...
    Cached Medicine Technology:With 2009 H1N1 Cases on the Rise, New CDC-Recommended Vaccine Helps Protect Families Against Illness 2With 2009 H1N1 Cases on the Rise, New CDC-Recommended Vaccine Helps Protect Families Against Illness 3
    Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical...
    Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
    Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical...
    ... The LT-Cage device restores ... with significantly less reaming ... Medtronic Sofamor Danek's Tapered ... to easily and reproducibly ...
    Medicine Products: